Your browser doesn't support javascript.
loading
A Founder Mutation in VPS11 Causes an Autosomal Recessive Leukoencephalopathy Linked to Autophagic Defects.
Zhang, Jinglan; Lachance, Véronik; Schaffner, Adam; Li, Xianting; Fedick, Anastasia; Kaye, Lauren E; Liao, Jun; Rosenfeld, Jill; Yachelevich, Naomi; Chu, Mary-Lynn; Mitchell, Wendy G; Boles, Richard G; Moran, Ellen; Tokita, Mari; Gorman, Elizabeth; Bagley, Kaytee; Zhang, Wei; Xia, Fan; Leduc, Magalie; Yang, Yaping; Eng, Christine; Wong, Lee-Jun; Schiffmann, Raphael; Diaz, George A; Kornreich, Ruth; Thummel, Ryan; Wasserstein, Melissa; Yue, Zhenyu; Edelmann, Lisa.
Afiliação
  • Zhang J; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
  • Lachance V; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, United States of America.
  • Schaffner A; Department of Neurology, The Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
  • Li X; Department of Neurology, The Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
  • Fedick A; Department of Neurology, The Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
  • Kaye LE; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
  • Liao J; Departments of Anatomy/Cell Biology and Ophthalmology, Wayne State University School of Medicine, Detroit, Michigan, United States of America.
  • Rosenfeld J; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
  • Yachelevich N; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, United States of America.
  • Chu ML; Clinical Genetics Services, New York University Hospitals Center, New York, New York, United States of America.
  • Mitchell WG; Department of Neurology, New York University School of Medicine, New York, New York, United States of America.
  • Boles RG; Neurology Division, Children's Hospital Los Angeles, Los Angeles, California, United States of America.
  • Moran E; Division of Medical Genetics, Children's Hospital Los Angeles, Los Angeles, California, United States of America.
  • Tokita M; Courtagen Life Sciences, Woburn, Massachusetts, United States of America.
  • Gorman E; Clinical Genetics Services, NYU Langone Hospital for Joint Diseases, New York, New York, United States of America.
  • Bagley K; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, United States of America.
  • Zhang W; Baylor Miraca Genetics Laboratories, Houston, Texas, United States of America.
  • Xia F; Baylor Miraca Genetics Laboratories, Houston, Texas, United States of America.
  • Leduc M; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, United States of America.
  • Yang Y; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, United States of America.
  • Eng C; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, United States of America.
  • Wong LJ; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, United States of America.
  • Schiffmann R; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, United States of America.
  • Diaz GA; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, United States of America.
  • Kornreich R; Institute of Metabolic Disease, Baylor Research Institute, Dallas, Texas, United States of America.
  • Thummel R; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
  • Wasserstein M; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
  • Yue Z; Departments of Anatomy/Cell Biology and Ophthalmology, Wayne State University School of Medicine, Detroit, Michigan, United States of America.
  • Edelmann L; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
PLoS Genet ; 12(4): e1005848, 2016 Apr.
Article em En | MEDLINE | ID: mdl-27120463
ABSTRACT
Genetic leukoencephalopathies (gLEs) are a group of heterogeneous disorders with white matter abnormalities affecting the central nervous system (CNS). The causative mutation in ~50% of gLEs is unknown. Using whole exome sequencing (WES), we identified homozygosity for a missense variant, VPS11 c.2536T>G (p.C846G), as the genetic cause of a leukoencephalopathy syndrome in five individuals from three unrelated Ashkenazi Jewish (AJ) families. All five patients exhibited highly concordant disease progression characterized by infantile onset leukoencephalopathy with brain white matter abnormalities, severe motor impairment, cortical blindness, intellectual disability, and seizures. The carrier frequency of the VPS11 c.2536T>G variant is 1250 in the AJ population (n = 2,026). VPS11 protein is a core component of HOPS (homotypic fusion and protein sorting) and CORVET (class C core vacuole/endosome tethering) protein complexes involved in membrane trafficking and fusion of the lysosomes and endosomes. The cysteine 846 resides in an evolutionarily conserved cysteine-rich RING-H2 domain in carboxyl terminal regions of VPS11 proteins. Our data shows that the C846G mutation causes aberrant ubiquitination and accelerated turnover of VPS11 protein as well as compromised VPS11-VPS18 complex assembly, suggesting a loss of function in the mutant protein. Reduced VPS11 expression leads to an impaired autophagic activity in human cells. Importantly, zebrafish harboring a vps11 mutation with truncated RING-H2 domain demonstrated a significant reduction in CNS myelination following extensive neuronal death in the hindbrain and midbrain. Thus, our study reveals a defect in VPS11 as the underlying etiology for an autosomal recessive leukoencephalopathy disorder associated with a dysfunctional autophagy-lysosome trafficking pathway.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Autofagia / Efeito Fundador / Proteínas de Transporte Vesicular / Leucoencefalopatias / Genes Recessivos / Mutação Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Adult / Animals / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: PLoS Genet Assunto da revista: GENETICA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Autofagia / Efeito Fundador / Proteínas de Transporte Vesicular / Leucoencefalopatias / Genes Recessivos / Mutação Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Adult / Animals / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: PLoS Genet Assunto da revista: GENETICA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos